ZAVESCA (miglustat) capsules

Zavesca (Miglustat)

ZAVESCA

miglustat

100 mg

Actelion Pharmaceuticals, Inc.

Medical Use

Zavesca (miglustat) is a medication that inhibits glucosylceramide synthase and is used as a standalone treatment for adults with mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not suitable.

Dosage Instructions: For adults with type 1 Gaucher disease, the recommended dose is one 100 mg capsule taken orally three times a day at regular intervals. If a dose is missed, the next capsule should be taken at the usual scheduled time. Due to potential side effects like tremors or diarrhea, some patients may need to reduce the dosage to one 100 mg capsule once or twice daily.